Lara Sullivan, Pyxis Oncology CEO
Pyxis taking scalpel to preclinical pipeline, stops development on half — for now
A Cambridge, MA biotech is looking to push to the clinic, and it’s willing to throw other candidates to the wayside.
Pyxis Oncology put out …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
